These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 2479967)
21. Scope and limitations of therapy with plasma substitutes: differential indication for substitutes, blood preparations and electrolyte solutions. Reissigl H Bibl Haematol; 1969; 33():32-54. PubMed ID: 4914355 [No Abstract] [Full Text] [Related]
22. [Volume substitution using plasma substitutes]. Lutz H Med Welt; 1972 Jan; 23(3):79-82. PubMed ID: 5018427 [No Abstract] [Full Text] [Related]
23. [Experimental studies on the effectiveness of various volume expanding substances in the treatment of hemorrhagic shock]. Lutz H; Just OH Klin Med Osterr Z Wiss Prakt Med; 1967; 22(3):131-4. PubMed ID: 5632099 [No Abstract] [Full Text] [Related]
25. To which extent is the clinical use of dextran, gelatin and hydroxyethyl starch influenced by the incidence and severity of anaphylactoid reactions? Collins JA; Litwin MS; Lutz H; Klose R; Ring J; Thorén L; Tschirren B; Lundsgaard-Hansen P Vox Sang; 1979; 36(1):39-49. PubMed ID: 85370 [No Abstract] [Full Text] [Related]
26. The therapeutic effect of gelatin and dextran plasma substitutes as evaluated by different criteria. Lundsgaard-Hansen P Bibl Haematol; 1969; 33():194-208. PubMed ID: 5383990 [No Abstract] [Full Text] [Related]
31. Quantity may be more important than type of intravenous fluid. Silversides JA; Ferguson AJ Crit Care Med; 2012 Feb; 40(2):709-10; author reply 710-1. PubMed ID: 22249072 [No Abstract] [Full Text] [Related]
32. Hemodynamic responses to whole blood and blood substitutes in clinical shock. Carey JS; Woodward NW; Brown R; Mohr P; Seward P; Shoemaker WC Surg Forum; 1965; 16():31-3. PubMed ID: 5835174 [No Abstract] [Full Text] [Related]
33. [Reply to the article of A. Hässig: "Shock problems and blood replacement with special reference to the expander problem". (This j. 15, p.271, 1966)]. Gruber UF; Allgöwer M Anaesthesist; 1966 Oct; 15(10):332-4. PubMed ID: 5993980 [No Abstract] [Full Text] [Related]
34. [Animal experimental studies on the effect of colloidal plasma substitutes in canine hemorrhagic shock]. Lutz H Z Gesamte Exp Med Einschl Exp Chir; 1968 Apr; 146(4):383-96. PubMed ID: 5671891 [No Abstract] [Full Text] [Related]
35. [On the problem of plasma substitutes. Conclusion]. Lundsgaard-Hansen P Helv Chir Acta; 1967 Dec; 34(6):566-8. PubMed ID: 5587955 [No Abstract] [Full Text] [Related]
36. [Blood and colloidal plasma volume expanders. Blood circulation changes and differential indication]. Thimme W; Dissmann W; Eisele R Med Welt; 1970 Mar; 12():477-8 passim. PubMed ID: 5444235 [No Abstract] [Full Text] [Related]
37. [Use of plasma substitutes in volume substitution]. Lundsgaard-Hansen P Bibl Haematol; 1971; 37():299-306. PubMed ID: 4945042 [No Abstract] [Full Text] [Related]
38. [Comments on the problem of plasma substitutes in military medicine and emergencies]. Allgöwer M Helv Chir Acta; 1967 Dec; 34(6):551-65. PubMed ID: 5587954 [No Abstract] [Full Text] [Related]
39. Blood and blood substitutes for treating hemorragic shock. Buchanan EC Am J Hosp Pharm; 1977 Jun; 34(6):631-6. PubMed ID: 879185 [TBL] [Abstract][Full Text] [Related]